Oral semaglutide is currently approved under the brand name Rybelsus ® as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Based on these findings, ...

Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for ...

Gestational diabetes mellitus (GDM) is a pervasive metabolic disorder associated with a spectrum of long-term adverse ...

"These results provide reassurance and can assist clinicians in making informed treatment decisions when selecting metformin ...

As such, they conclude, "These results provide reassurance and can assist clinicians in making informed treatment decisions ...

USA: The recent analysis from the VICTORIA trial has highlighted the potential benefits of vericiguat in managing ...

On Monday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the SOUL Phase 3 cardiovascular outcomes trial.

USA: A recent narrative review has highlighted the effectiveness of GLP-1 receptor agonists (RAs) in treating type 2 diabetes ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

Some 61 million people live with diabetes in Europe, of whom about 90% have type 2 diabetes (T2D) [1], in which the body may not produce enough insulin and/or not be able to use the insulin it ...

“These results provide reassurance and can assist clinicians in making informed treatment decisions when selecting metformin ...

Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes ...